NASDAQ · Analyst Forecast

HCW Biologics Inc. (HCWB) Stock Forecast & Price Target

$0.78 NASDAQ: HCWB Market Cap $270013

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering HCW Biologics Inc. (HCWB), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For HCW Biologics Inc., analysts forecast revenue falling from $27,000 in 2025 to $3,772 in 2030; the average estimate for 2030 earnings per share is −$0.62; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$27,000$27,000$27,0001
2026$6.68M$6.68M$6.68M1
2027$33.73M$33.73M$33.73M1
2028$45.65M$45.65M$45.65M1
2029$6,429$6,429$6,4291
2030$3,772$3,772$3,7721

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$31.38−$31.38−$31.381
2026−$4.72−$4.72−$4.721
2027−$1.05−$1.05−$1.051
2028−$0.73−$0.73−$0.731
2029−$0.58−$0.58−$0.581
2030−$0.62−$0.62−$0.621

HCW Biologics Inc. (HCWB) forecast — frequently asked questions

What are analysts forecasting for HCW Biologics Inc.'s earnings?

The average analyst estimate for HCW Biologics Inc. (HCWB) earnings per share in 2030 is -0.62, with individual estimates between -0.62 and -0.62.

How much revenue is HCW Biologics Inc. expected to make?

Analysts forecast HCW Biologics Inc. (HCWB) revenue of $3,772 in 2030, based on 1 published estimates.

How many analysts cover HCWB?

1 analyst contribute estimates for HCW Biologics Inc. (HCWB). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.